OncoGenesis has developed a next generation cervical sample collector for personal use. The iPap™ Personal Cervical Sample Collector is designed for self collection by women, whether in developing world markets or as a take home test from the corner drugstore. Can be used for collection of various samples from cervical cells to STD’s.
iPap™ is a new product OncoGenesis is taking to market to offer a woman the means of collecting her own sample with a patented collector and includes subsequent laboratory analysis by more sensitive and specific means. Some women are prohibited and/or discouraged from going for regular cervical cancer screening due to cultural practices and religious beliefs. For this reason, OncoGenesis is offering a simple, inexpensive, and convenient private self-test that respects the individual privacy of women who might otherwise be reluctant to undergo screening.
The results of a recent study published in 2012 involved a field trial of cervical cancer screening using self-collected samples. This study included 20,461 women from India, Nicaragua and Uganda, and found that the sensitivity of a self-collected HPV sample (69.6 percent) was significantly better than the Pap smear (58.4 percent), and almost equal to that of a health worker-collected cervical sample (81.5 percent), for detection of precancerous cervical lesions. The fact that self-collected specimens from women who have received appropriate instruction produce test results similar to cervical specimens collected by health-care professionals supports the intention of OncoGenesis to market a self-collection, lab based, antibody kit used for personal cervical cancer screening.
The iPap sample is processed in a laboratory using standard procedures and equipment. This product is targeted for distribution to women in countries where women are often prohibited by religious or cultural beliefs to undergo a cervical sample collection process by medical personnel.
Pending FDA clearance in the U.S.